167 related articles for article (PubMed ID: 9699922)
21. Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses.
Schäfer K; Ukida M; Steffen C; Bode C; Zelder O; Bode JC
Res Exp Med (Berl); 1985; 185(1):35-44. PubMed ID: 2857496
[TBL] [Abstract][Full Text] [Related]
22. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
Oria M; Romero-Giménez J; Arranz JA; Riudor E; Raguer N; Córdoba J
J Hepatol; 2012 Jan; 56(1):109-14. PubMed ID: 21835138
[TBL] [Abstract][Full Text] [Related]
23. Altered glutamine metabolism in rat portal drained viscera and hindquarter during hyperammonemia.
Dejong CH; Kampman MT; Deutz NE; Soeters PB
Gastroenterology; 1992 Mar; 102(3):936-48. PubMed ID: 1347032
[TBL] [Abstract][Full Text] [Related]
24. [Prevention and treatment of hepatic encephalopathy].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
[TBL] [Abstract][Full Text] [Related]
25. Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis.
Butterworth RF; Girard G; Giguère JF
J Neurochem; 1988 Aug; 51(2):486-90. PubMed ID: 3392540
[TBL] [Abstract][Full Text] [Related]
26. An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy.
Yilmaz S; Kirimlioglu V; Katz D; Basak K; Caglikulekci M; Kayaalp C; Yildirim B; Akoglu M
Dig Dis Sci; 2002 Sep; 47(9):1943-52. PubMed ID: 12353834
[TBL] [Abstract][Full Text] [Related]
27. Ammonia metabolism in normal and portacaval-shunted rats.
Cooper AJ
Adv Exp Med Biol; 1990; 272():23-46. PubMed ID: 2103690
[TBL] [Abstract][Full Text] [Related]
28. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
[TBL] [Abstract][Full Text] [Related]
29. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
[TBL] [Abstract][Full Text] [Related]
30. Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats.
Olde Damink SW; Dejong CH; Deutz NE; Soeters PB
Metab Brain Dis; 1997 Jun; 12(2):121-35. PubMed ID: 9203157
[TBL] [Abstract][Full Text] [Related]
31. Region-selective reductions in activities of glutamine synthetase in rat brain following portacaval anastomosis.
Girard G; Giguère JF; Butterworth RF
Metab Brain Dis; 1993 Dec; 8(4):207-15. PubMed ID: 7910653
[TBL] [Abstract][Full Text] [Related]
32. A 15N NMR study of in vivo cerebral glutamine synthesis in hyperammonemic rats.
Kanamori K; Parivar F; Ross BD
NMR Biomed; 1993; 6(1):21-6. PubMed ID: 8096147
[TBL] [Abstract][Full Text] [Related]
33. Decreased ureagenesis from alanine, but not from ammonia and glutamine, in the perfused rat liver after partial hepatectomy.
Moriyama M; Makiyama I; Shiota M; Uesugi K; Kannan Y; Ohta M; Kimura K; Sugano T
Hepatology; 1996 Jun; 23(6):1584-90. PubMed ID: 8675181
[TBL] [Abstract][Full Text] [Related]
34. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design.
Staedt U; Leweling H; Gladisch R; Kortsik C; Hagmüller E; Holm E
J Hepatol; 1993 Nov; 19(3):424-30. PubMed ID: 8151104
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
Chen MF; Li RC; Chen CH; Gao XC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
[TBL] [Abstract][Full Text] [Related]
36. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
37. Cerebral GABA-ergic and glutamatergic function in hepatic encephalopathy.
Butterworth RF; Lavoie J; Giguère JF; Layrargues GP; Bergeron M
Neurochem Pathol; 1987; 6(1-2):131-44. PubMed ID: 2888065
[TBL] [Abstract][Full Text] [Related]
38. Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portacaval-shunted rats.
Hearn TJ; Coleman AE; Lai JC; Griffith OW; Cooper AJ
Hepatology; 1989 Nov; 10(5):822-8. PubMed ID: 2807161
[TBL] [Abstract][Full Text] [Related]
39. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
[TBL] [Abstract][Full Text] [Related]
40. [Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K
Nihon Yakurigaku Zasshi; 1995 Feb; 105(2):97-109. PubMed ID: 7737597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
